Monsanto signs option agreement to support biologicals platform

15:01 PM | January 13, 2014 | Rebecca Coons

Tekmira Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, announced today that it has signed an option agreement under which Monsanto may obtain a license to use Tekmira's...